C5a Regulates IL-12+DC Migration to Induce Pathogenic Th1 and Th17 Cells in Sepsis

被引:21
作者
Ma, Ning [1 ,2 ]
Xing, Chen [1 ]
Xiao, He [1 ]
Wang, Yi [1 ]
Wang, Ke [1 ]
Hou, Chunmei [1 ]
Han, Gencheng [1 ]
Chen, Guojiang [1 ]
Marrero, Bernadette [3 ]
Wang, Yujuan [4 ]
Shen, Beifen [1 ]
Li, Yan [1 ]
Wang, Renxi [1 ]
机构
[1] Chinese Acad Med Sci, Inst Basic Med Sci, Immunol Lab, Beijing 100730, Peoples R China
[2] Jilin Univ, Dept Rheumatol, Hosp 1, Changchun 130023, Peoples R China
[3] NEI, Mol Immunol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA
[4] NEI, Immunopathol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA
来源
PLOS ONE | 2013年 / 8卷 / 07期
基金
北京市自然科学基金;
关键词
RECEPTOR; MODEL; DEFINITIONS; NEUTROPHILS; EXPRESSION; APOPTOSIS; CYTOKINE; ANTI-C5A; SHOCK; RAT;
D O I
10.1371/journal.pone.0069779
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: It is well known that complement system C5a is excessively activated during the onset of sepsis. However, it is unclear whether C5a can regulate dentritic cells (DCs) to stimulate adaptive immune cells such as Th1 and Th17 in sepsis. Methods: Sepsis was induced by cecal ligation and puncture (CLP). CLP-induced sepsis was treated with anti-C5a or IL-12. IL-12(+)DC, IFN gamma(+)Th1, and IL-17(+)Th17 cells were analyzed by flow cytometry. IL-12 was measured by ELISA. Results: Our studies here showed that C5a induced IL-12(+)DC cell migration from the peritoneal cavity to peripheral blood and lymph nodes. Furthermore, IL-12(+)DC cells induced the expansion of pathogenic IFN gamma(+)Th1 and IL-17(+)Th17 cells in peripheral blood and lymph nodes. Moreover, IL-12, secreted by DC cells in the peritoneal cavity, is an important factor that prevents the development of sepsis. Conclusion: Our data suggests that C5a regulates IL-12(+)DC cell migration to induce pathogenic Th1 and Th17 cells in sepsis.
引用
收藏
页数:8
相关论文
共 29 条
  • [1] Immunobiology of dendritic cells
    Banchereau, J
    Briere, F
    Caux, C
    Davoust, J
    Lebecque, S
    Liu, YT
    Pulendran, B
    Palucka, K
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 767 - +
  • [2] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [3] Protective effects of C5a blockade in sepsis
    Czermak, BJ
    Sarma, V
    Pierson, CL
    Warner, RL
    Huber-Lang, M
    Bless, NM
    Schmal, H
    Friedl, HP
    Ward, PA
    [J]. NATURE MEDICINE, 1999, 5 (07) : 788 - 792
  • [4] Czermak BJ, 2013, J IMMUNOL, V162, P5437
  • [5] GOLDSTEI.IM, 1974, J IMMUNOL, V113, P1583
  • [6] Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis
    Guo, RF
    Huber-Lang, M
    Wang, X
    Sarma, V
    Padgaonkar, VA
    Craig, RA
    Riedemann, NC
    McClintock, SD
    Hlaing, T
    Shi, MM
    Ward, PA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (10) : 1271 - 1280
  • [7] Role of C5A in inflammatory responses
    Guo, RF
    Ward, PA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 : 821 - 852
  • [8] Altered neutrophil trafficking during sepsis
    Guo, RF
    Riedemann, NC
    Laudes, IJ
    Sarma, VJ
    Kunkel, RG
    Dilley, KA
    Paulauskis, JD
    Ward, PA
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (01) : 307 - 314
  • [9] Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies
    Hopken, U
    Mohr, M
    Struber, A
    Montz, H
    Burchardi, H
    Gotze, O
    Oppermann, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (05) : 1103 - 1109
  • [10] Complement-induced impairment of innate immunity during sepsis
    Huber-Lang, MS
    Younkin, EM
    Sarma, JV
    McGuire, SR
    Lu, KT
    Guo, RF
    Padgaonkar, VA
    Curnutte, JT
    Erickson, R
    Ward, PA
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (06) : 3223 - 3231